Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico antes de ser publicado, versión del autor (Preprint)

Universal scaling laws rule explosive growth in human cancers

  • Pérez-García, Víctor M
  • Calvo, Gabriel F
  • Bosque, Jesús J
  • León-Triana, Odelaisy
  • Jiménez, Juan
  • Perez-Beteta, Julián
  • Belmonte-Beitia, Juan
  • Zhu, Lucía
  • García-Gómez, Pedro
  • Sánchez-Gómez, Pilar
  • Hernandez-SanMiguel, Esther
  • Hortigüela, Rafael
  • Azimzade, Youness
  • Molina-García, David
  • Martinez, Álvaro
  • Acosta Rojas, Ángel
  • Ortiz de Mendivil, Ana
  • Vallette, Francois
  • Schucht, Philippe
  • Murek, Michael
  • Pérez-Cano, María
  • Albillo, David
  • Honguero Martínez, Antonio F
  • Jiménez Londoño, Germán A
  • Arana, Estanislao
  • García Vicente, Ana M
  • Valiente, Manuel
Most physical and other natural systems are complex entities composed of a large number of interacting individual elements. It is a surprising fact that they often obey the so-called scaling laws relating an observable quantity with a measure of the size of the system. Here we describe the discovery of universal superlinear metabolic scaling laws in human cancers. This dependence underpins increasing tumour aggressiveness, due to evolutionary dynamics, which leads to an explosive growth as the disease progresses. We validated this dynamic using longitudinal volumetric data of different histologies from large cohorts of cancer patients. To explain our observations we put forward increasingly-complex biologically-inspired mathematical models that captured the key processes governing tumor growth. Our models predicted that the emergence of superlinear allometric scaling laws is an inherently three-dimensional phenomenon. Moreover, the scaling laws thereby identified allowed us to define a set of metabolic metrics with prognostic value, thus providing added clinical utility to the base findings.
Repisalud
Publicación Artículo científico antes de ser publicado, versión del autor (Preprint)

Vascular co-option in brain metastasis.

  • García-Gómez, Pedro
  • Valiente, Manuel
Vascular co-option by brain metastasis-initiating cells has been demonstrated as a critical step in organ colonization. The physical interaction between the cancer cell and the endothelial cell is mediated by integrins and L1CAM and could be involved in aggressive growth but also latency and immune evasion. The key involvement of vascular co-option in brain metastasis has created an emerging field that aims to identify critical targets as well as effective inhibitors with the goal of preventing brain metastases.
Repisalud
Publicación Artículo científico antes de ser publicado, versión del autor (Preprint)

Brain metastasis models: What should we aim to achieve better treatments?

  • Masmudi-Martín, M
  • Zhu, L
  • Sanchez-Navarro, M
  • Priego, N
  • Casanova-Acebes, M
  • Giralt, E
  • Masmudi-Martín, M.
  • Zhu, L.
  • Sanchez-Navarro, M.
  • Priego, N.
  • Casanova-Acebes, M.
  • Ruiz-Rodado, V
  • Giralt, E.
  • Valiente, Manuel
Brain metastasis is emerging as a unique entity in oncology based on its particular biology and, consequently, the pharmacological approaches that should be considered. We discuss the current state of modelling this specific progression of cancer and how these experimental models have been used to test multiple pharmacologic strategies over the years. In spite of pre-clinical evidences demonstrating brain metastasis vulnerabilities, many clinical trials have excluded patients with brain metastasis. Fortunately, this trend is getting to an end given the increasing importance of secondary brain tumors in the clinic and a better knowledge of the underlying biology. We discuss emerging trends and unsolved issues that will shape how we will study experimental brain metastasis in the years to come.